ligand.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi LGND
The actual operating profit dynamics of Ligand Pharmaceuticals (LGND) depend on royalties from oncology patent licensing. A compact staff of high-paid biochemists ensures stability, yet profit volatility is driven by partner success and pricing pressure in the US. The current trend of the curve confirms business resilience, and 74.21 captures the current state of the company's operating earnings parameter.
Ringkesan rincian data analitis Ligand Pharma (LGND)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Ligand Pharmaceuticals|LGND - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Ligand Pharma|LGND - Gunggung utang perusahaan|Utang-utang marang aset resik Ligand Pharmaceuticals|LGND - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Ligand|Rasio cepet ligand.com
- statistik bathi lan rasio pasar:
LGND - Bathi resik perusahaan|Prakiraan bathi resik Ligand Pharmaceuticals|LGND - Pangali P/E|Rasio rega marang bathi mangsa ngarep Ligand Pharma|LGND - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Ligand Pharmaceuticals Incorporated|LGND - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Ligand|LGND - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan ligand.com|LGND - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Ligand Pharmaceuticals
- indikator pendapatan dodolan lan penghasilan bisnis:
Ringkesan analitik perusahaan:LGND Ligand Pharmaceuticals
This metric measures actual cash flow from core operations before debt service, allowing investors to assess the business's resilience to rising interest rates. Analyzing the EBITDA history confirms the effectiveness of the Ligand Pharmaceuticals (LGND) model, where royalty collection and the absence of proprietary manufacturing plants minimize capital expenditures and environmental risks, thereby maximizing operational liquidity.
Karo sapa Ligand Pharmaceuticals saingan
Bathi perusahaan sadurunge pajak, bunga, lan amortisasi HLN (Haleon plc)|KVUE: Bathi operasional sadurunge ngurangi amortisasi|Verona Pharma - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MENS: Bathi operasional EBITDA|Amneal Pharmaceuticals Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|PRGO (Perrigo Company PLC) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi alvotech.com ALVO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Liquidia (LQDA)|GLPG (Galapagos) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ANIP (ANI Pharmaceuticals Inc)|MNKD - Bathi operasional sadurunge ngurangi amortisasi|AMPH - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|PCRX - Bathi operasional EBITDA|ARS Pharmaceuticals Inc (SPRY) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Theravance Biopharma Inc (TBPH)|AQST (aquestive.com) - Bathi operasional EBITDA|SCPH: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tectonic Therapeutic, Inc. (TECX)|Tonix Pharmaceuticals Holding Corp. - Bathi operasional sadurunge amortisasi|China SXT Pharmaceuticals - Bathi operasional sadurunge ngurangi amortisasi|EPRX: Bathi operasional sadurunge amortisasi|BHST: Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Invizyne|Oramed Pharmaceuticals Inc. (ORMP) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|ENTX (Entera Bio Ltd) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi HYFT|ABVC BioPharma, Inc. - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi operasional EBITDA CPIX|Pendapatan operasional sadurunge ngurangi amortisasi Quantum BioPharma Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi FibroGen FGEN|Bathi operasional EBITDA telomirpharma.com TELO|Rani Therapeutics Inc - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SNYR (synergychc.com)|Rallybio (RLYB) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi Lexaria Bioscience Corp|Bathi operasional sadurunge ngurangi amortisasi PULM|PTHL - Bathi operasional sadurunge potongan amortisasi|Bathi operasional EBITDA APM|Pendapatan operasional sadurunge ngurangi amortisasi Lyra Therapeutics|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Impact BioMedical Inc IBO|TNFA - Bathi operasional sadurunge ngurangi amortisasi|cbdMD, Inc. - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi PRFX (PainReform Ltd.)|CYTO (altamiratherapeutics.com) - Bathi operasional sadurunge ngurangi amortisasi|LIPO: Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|OPTN (Optinose) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Pieris (PIRS)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Procaps Group S.A. (PROC)|Bathi operasional EBITDA petrospharma.com (PTPI)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Qilian International Holding QLI|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi SLRN|TFF Pharmaceuticals, Inc. - Bathi operasional EBITDA
